5-132198270-T-C
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_001365677.2(P4HA2):āc.1307A>Gā(p.Asn436Ser) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000427 in 1,614,230 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_001365677.2 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
P4HA2 | NM_001365677.2 | c.1307A>G | p.Asn436Ser | missense_variant, splice_region_variant | 12/15 | ENST00000379104.7 | |
P4HA2 | NM_001017974.2 | c.1365+51A>G | intron_variant | ENST00000360568.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
P4HA2 | ENST00000379104.7 | c.1307A>G | p.Asn436Ser | missense_variant, splice_region_variant | 12/15 | 1 | NM_001365677.2 | P4 | |
P4HA2 | ENST00000360568.8 | c.1365+51A>G | intron_variant | 1 | NM_001017974.2 | A1 |
Frequencies
GnomAD3 genomes AF: 0.00244 AC: 372AN: 152222Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000581 AC: 146AN: 251470Hom.: 1 AF XY: 0.000464 AC XY: 63AN XY: 135912
GnomAD4 exome AF: 0.000216 AC: 316AN: 1461890Hom.: 3 Cov.: 32 AF XY: 0.000194 AC XY: 141AN XY: 727244
GnomAD4 genome AF: 0.00245 AC: 373AN: 152340Hom.: 1 Cov.: 32 AF XY: 0.00220 AC XY: 164AN XY: 74492
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 18, 2018 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
P4HA2-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 06, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at